The use of Cryotherapy and Albendazole as a Beneficial Cutaneous Larva Migrans Therapy: A Case Report

Aims: To describe the effect of combination albendazole and cryotherapy as a spesific CLM therapy.

Presentation of case: A 21-year-old man reported a winding reddish patches that felt itchy and hot since 1 month ago. Erythema papules and hyperpigmented patches and hyperpigmented macules in the serpiginous form were found at right brachial, right genu, and right cruris regions. The patient was given albendazole therapy 1x400 mg for 3 days orally and mixed cream (albendazole 400 mg, mupirocin, and clobetasol propionate) for 7 days showed only minimal clinical cure. For optimal results, we combine albendazole therapy with cryotherapy with liquid nitrogen. Combination therapy resulted in satisfactory improvement and no recurrences after therapy.

Discussion: The first-line therapy for the treatment of CLM cases is ivermectin 0.15-0.2 mg / kg / day and second-line albendazole 400 mg given for 3 consecutive days. Alternative therapy such as cryotherapy in an unsuccessful case with oral therapy and also to prevent recurrency.

Conclusion: Administration of albendazole combination therapy with cryotherapy using liquid nitrogen as management of CML therapy is effective in unsuccessful case to oral therapy.